HPTN
Oct 17, 2024 | In the Media
“Transgender women have one of the highest HIV prevalence of any population yet continue to struggle to access and adhere to PrEP,” said ICAP’s Wafaa El-Sadr. “Tailoring strategies to address the unique needs of this population is critical to...
Sep 10, 2024 | In the Media
Dr. Harriet Nuwagaba-Biribonwoha, an HPTN 084 and HPTN 104 study team member, is an assistant professor of Epidemiology at Columbia University Mailman School of Public Health, research director at ICAP in Eswatini, and CRS leader at the Eswatini Prevention Center...
Sep 9, 2021 | Stories from the Field
In the streets of Harlem and the Bronx, a new “set of wheels” is getting noticed. All summer long, ICAP’s state-of-the-art mobile clinic has been making rounds in these bustling communities, drawing plenty of attention when it rolls up to spend the day in a busy...
May 17, 2021 | Stories from the Field
Growing up in Cameroon, Rita Sondengam was no stranger to the faces that hide behind the numbers of some of the world’s most pressing public health emergencies like HIV/AIDS, malaria, dysentery, and TB. But for her, these weren’t just statistics, faceless numbers in a...
Feb 17, 2021 | News
Sponsored by the National Institutes of Health (NIH), the HIV Prevention Trials Network (HPTN) and the HIV Vaccine Trials Network (HVTN) jointly conducted the Antibody Mediated Prevention (AMP) study which tested a new innovation for HIV prevention. Traditionally,...